Coping with stressful life events: Cognitive emotion regulation profiles and depressive symptoms in adolescents / Marieke W. H. VAN DEN HEUVEL in Development and Psychopathology, 32-3 (August 2020)  

Public ISBD [article]  inDevelopment and Psychopathology > 32-3 (August 2020) . - p.985-995 Titre : Coping with stressful life events: Cognitive emotion regulation profiles and depressive symptoms in adolescents Type de document : Texte imprimé et/ou numérique Auteurs : Marieke W. H. VAN DEN HEUVEL, Auteur ; Yvonne A. J. STIKKELBROEK, Auteur ; Denise H. M. BODDEN, Auteur ; Anneloes L. VAN BAAR, Auteur Article en page(s) : p.985-995 Langues : Anglais (eng) Mots-clés : adolescents  cognitive emotion regulation strategies  depressive symptoms  latent profiles  stressful life events Index. décimale : PER Périodiques Résumé : Cognitive strategies that adolescents use to cope with negative emotions might show distinct profiles of cognitive emotion regulation strategies, which could be differentially associated with depressive symptoms. In total, 411 Dutch adolescents who had experienced at least one stressful life event that required some coping strategy participated in this study, including 334 nonclinical and 77 clinically depressed adolescents (12-21 years). A person-centered approach with Latent Profile Analysis was used to identify underlying profiles of cognitive emotion regulation based on the adolescents' reports of their use of cognitive emotion regulation strategies when they were confronted with stressful life events. Nine different strategies, five adaptive and four maladaptive, were used as indicators. Four profiles with distinct features were found in the nonclinical sample, as well as in the combined sample of nonclinical and clinically depressed adolescents: Low Regulators, High Regulators, Maladaptive Regulators, and Adaptive Regulators. In both samples, the High Regulators profile was most commonly used, followed by the Adaptive, Maladaptive, and Low Regulators profile. Maladaptive Regulators endorsed higher levels of depressive symptoms relative to Low, High, and Adaptive Regulators. The findings underscore the utility of using a person-centered approach in order to identify patterns of cognitive emotion regulation deficits in psychopathology. En ligne : http://dx.doi.org/10.1017/s0954579419000920 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=429 [article] Coping with stressful life events: Cognitive emotion regulation profiles and depressive symptoms in adolescents [Texte imprimé et/ou numérique] / Marieke W. H. VAN DEN HEUVEL, Auteur ; Yvonne A. J. STIKKELBROEK, Auteur ; Denise H. M. BODDEN, Auteur ; Anneloes L. VAN BAAR, Auteur . - p.985-995. Langues : Anglais (eng) in Development and Psychopathology > 32-3 (August 2020) . - p.985-995 Mots-clés : adolescents  cognitive emotion regulation strategies  depressive symptoms  latent profiles  stressful life events Index. décimale : PER Périodiques Résumé : Cognitive strategies that adolescents use to cope with negative emotions might show distinct profiles of cognitive emotion regulation strategies, which could be differentially associated with depressive symptoms. In total, 411 Dutch adolescents who had experienced at least one stressful life event that required some coping strategy participated in this study, including 334 nonclinical and 77 clinically depressed adolescents (12-21 years). A person-centered approach with Latent Profile Analysis was used to identify underlying profiles of cognitive emotion regulation based on the adolescents' reports of their use of cognitive emotion regulation strategies when they were confronted with stressful life events. Nine different strategies, five adaptive and four maladaptive, were used as indicators. Four profiles with distinct features were found in the nonclinical sample, as well as in the combined sample of nonclinical and clinically depressed adolescents: Low Regulators, High Regulators, Maladaptive Regulators, and Adaptive Regulators. In both samples, the High Regulators profile was most commonly used, followed by the Adaptive, Maladaptive, and Low Regulators profile. Maladaptive Regulators endorsed higher levels of depressive symptoms relative to Low, High, and Adaptive Regulators. The findings underscore the utility of using a person-centered approach in order to identify patterns of cognitive emotion regulation deficits in psychopathology. En ligne : http://dx.doi.org/10.1017/s0954579419000920 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=429

Research Review: Recommendations for reporting on treatment trials for child and adolescent anxiety disorders - an international consensus statement / Cathy CRESWELL in Journal of Child Psychology and Psychiatry, 62-3 (March 2021)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 62-3 (March 2021) . - p.255-269 Titre : Research Review: Recommendations for reporting on treatment trials for child and adolescent anxiety disorders - an international consensus statement Type de document : Texte imprimé et/ou numérique Auteurs : Cathy CRESWELL, Auteur ; Maaike H. NAUTA, Auteur ; Jennifer L. HUDSON, Auteur ; Sonja MARCH, Auteur ; Tessa REARDON, Auteur ; Kristian ARENDT, Auteur ; Denise H. M. BODDEN, Auteur ; Vanessa E. COBHAM, Auteur ; Caroline L. DONOVAN, Auteur ; Brynjar HALLDORSSON, Auteur ; Tina IN-ALBON, Auteur ; Shin-Ichi ISHIKAWA, Auteur ; Daniel Bach JOHNSEN, Auteur ; Maral JOLSTEDT, Auteur ; Rachel DE JONG, Auteur ; Leonie KREUZE, Auteur ; Lynn MOBACH, Auteur ; Ronald M RAPEE, Auteur ; Susan H. SPENCE, Auteur ; Mikael THASTUM, Auteur ; Elisabeth UTENS, Auteur ; Sarah VIGERLAND, Auteur ; Gro Janne WERGELAND, Auteur ; Cecilia A ESSAU, Auteur ; Anne Marie ALBANO, Auteur ; Brian CHU, Auteur ; Muniya KHANNA, Auteur ; Wendy K. SILVERMAN, Auteur ; Philip C. KENDALL, Auteur Article en page(s) : p.255-269 Langues : Anglais (eng) Mots-clés : Anxiety  treatment trials Index. décimale : PER Périodiques Résumé : BACKGROUND: Anxiety disorders in children and young people are common and bring significant personal and societal costs. Over the last two decades, there has been a substantial increase in research evaluating psychological and pharmacological treatments for anxiety disorders in children and young people and exciting and novel research has continued as the field strives to improve efficacy and effectiveness, and accessibility of interventions. This increase in research brings potential to draw together data across studies to compare treatment approaches and advance understanding of what works, how, and for whom. There are challenges to these efforts due largely to variation in studies' outcome measures and variation in the way study characteristics are reported, making it difficult to compare and/or combine studies, and this is likely to lead to faulty conclusions. Studies particularly vary in their reliance on child, parent, and/or assessor-based ratings across a range of outcomes, including remission of anxiety diagnosis, symptom reduction, and other domains of functioning (e.g., family relationships, peer relationships). METHODS: To address these challenges, we convened a series of international activities that brought together the views of key stakeholders (i.e., researchers, mental health professionals, young people, parents/caregivers) to develop recommendations for outcome measurement to be used in treatment trials for anxiety disorders in children and young people. RESULTS AND CONCLUSIONS: This article reports the results of these activities and offers recommendations for selection and reporting of outcome measures to (a) guide future research and (b) improve communication of what has been measured and reported. We offer these recommendations to promote international consistency in trial reporting and to enable the field to take full advantage of the great opportunities that come from data sharing going forward. En ligne : http://dx.doi.org/10.1111/jcpp.13283 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=443 [article] Research Review: Recommendations for reporting on treatment trials for child and adolescent anxiety disorders - an international consensus statement [Texte imprimé et/ou numérique] / Cathy CRESWELL, Auteur ; Maaike H. NAUTA, Auteur ; Jennifer L. HUDSON, Auteur ; Sonja MARCH, Auteur ; Tessa REARDON, Auteur ; Kristian ARENDT, Auteur ; Denise H. M. BODDEN, Auteur ; Vanessa E. COBHAM, Auteur ; Caroline L. DONOVAN, Auteur ; Brynjar HALLDORSSON, Auteur ; Tina IN-ALBON, Auteur ; Shin-Ichi ISHIKAWA, Auteur ; Daniel Bach JOHNSEN, Auteur ; Maral JOLSTEDT, Auteur ; Rachel DE JONG, Auteur ; Leonie KREUZE, Auteur ; Lynn MOBACH, Auteur ; Ronald M RAPEE, Auteur ; Susan H. SPENCE, Auteur ; Mikael THASTUM, Auteur ; Elisabeth UTENS, Auteur ; Sarah VIGERLAND, Auteur ; Gro Janne WERGELAND, Auteur ; Cecilia A ESSAU, Auteur ; Anne Marie ALBANO, Auteur ; Brian CHU, Auteur ; Muniya KHANNA, Auteur ; Wendy K. SILVERMAN, Auteur ; Philip C. KENDALL, Auteur . - p.255-269. Langues : Anglais (eng) in Journal of Child Psychology and Psychiatry > 62-3 (March 2021) . - p.255-269 Mots-clés : Anxiety  treatment trials Index. décimale : PER Périodiques Résumé : BACKGROUND: Anxiety disorders in children and young people are common and bring significant personal and societal costs. Over the last two decades, there has been a substantial increase in research evaluating psychological and pharmacological treatments for anxiety disorders in children and young people and exciting and novel research has continued as the field strives to improve efficacy and effectiveness, and accessibility of interventions. This increase in research brings potential to draw together data across studies to compare treatment approaches and advance understanding of what works, how, and for whom. There are challenges to these efforts due largely to variation in studies' outcome measures and variation in the way study characteristics are reported, making it difficult to compare and/or combine studies, and this is likely to lead to faulty conclusions. Studies particularly vary in their reliance on child, parent, and/or assessor-based ratings across a range of outcomes, including remission of anxiety diagnosis, symptom reduction, and other domains of functioning (e.g., family relationships, peer relationships). METHODS: To address these challenges, we convened a series of international activities that brought together the views of key stakeholders (i.e., researchers, mental health professionals, young people, parents/caregivers) to develop recommendations for outcome measurement to be used in treatment trials for anxiety disorders in children and young people. RESULTS AND CONCLUSIONS: This article reports the results of these activities and offers recommendations for selection and reporting of outcome measures to (a) guide future research and (b) improve communication of what has been measured and reported. We offer these recommendations to promote international consistency in trial reporting and to enable the field to take full advantage of the great opportunities that come from data sharing going forward. En ligne : http://dx.doi.org/10.1111/jcpp.13283 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=443

Societal costs of subclinical depressive symptoms in Dutch adolescents: a cost-of-illness study / Denise H. M. BODDEN in Journal of Child Psychology and Psychiatry, 63-7 (July 2022)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 63-7 (July 2022) . - p.771-780 Titre : Societal costs of subclinical depressive symptoms in Dutch adolescents: a cost-of-illness study Type de document : Texte imprimé et/ou numérique Auteurs : Denise H. M. BODDEN, Auteur ; Marieke W. H. VAN DEN HEUVEL, Auteur ; Rutger C. M. E. ENGELS, Auteur ; Carmen D. DIRKSEN, Auteur Article en page(s) : p.771-780 Langues : Anglais (eng) Mots-clés : Adolescent  Cost-Benefit Analysis  Depression/epidemiology  Depressive Disorder, Major  Humans  Reproducibility of Results  Surveys and Questionnaires  Adolescence  depression  economic evaluation Index. décimale : PER Périodiques Résumé : BACKGROUND: Subclinical depressive symptoms are highly prevalent among adolescents and are associated with negative consequences, which may pose an economic burden for society. We conducted a prevalence-based cost-of-illness study using a societal perspective to investigate the cost-of-illness of subclinical depressive symptoms among adolescents. METHODS: Using a bottom-up approach, cost questionnaires were assessed to measure costs from 237 Dutch families with an adolescent aged 11-18 with subclinical depressive symptoms (of which 34 met the criteria of a depressive disorder). The study is registered in the Dutch Trial Register (Trial NL5584/NTR6176; www.trialregister.nl/trial/5584). RESULTS: Our calculations show that adolescents with subclinical depressive symptoms cost the Dutch society more than ?42?million annually, expressed in costs related to depressive symptoms. Secondary analyses were performed to test the reliability and stability of the costs. When costs related to psychological problems were considered, the annual costs amounted to ?67?million. The total societal costs related to physical problems amounted to approximately ?126?million. All costs combined (depressive, psychological, behavioural and physical problems and other reasons) amounted to a ?243?million. Total costs were highest for physical-related problems of the adolescent (52% of the total costs), followed by psychological (28%), depressive (17%) and behavioural problems (1%). Using an international prevalence rate, societal costs related to depressive symptoms resulted in ?54?million a year. CONCLUSIONS: Cost-effective prevention programmes seem warranted given the high societal costs and risk of future costs as subclinical depressive symptoms could be a precursor of clinical depression later in life. En ligne : http://dx.doi.org/10.1111/jcpp.13517 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=477 [article] Societal costs of subclinical depressive symptoms in Dutch adolescents: a cost-of-illness study [Texte imprimé et/ou numérique] / Denise H. M. BODDEN, Auteur ; Marieke W. H. VAN DEN HEUVEL, Auteur ; Rutger C. M. E. ENGELS, Auteur ; Carmen D. DIRKSEN, Auteur . - p.771-780. Langues : Anglais (eng) in Journal of Child Psychology and Psychiatry > 63-7 (July 2022) . - p.771-780 Mots-clés : Adolescent  Cost-Benefit Analysis  Depression/epidemiology  Depressive Disorder, Major  Humans  Reproducibility of Results  Surveys and Questionnaires  Adolescence  depression  economic evaluation Index. décimale : PER Périodiques Résumé : BACKGROUND: Subclinical depressive symptoms are highly prevalent among adolescents and are associated with negative consequences, which may pose an economic burden for society. We conducted a prevalence-based cost-of-illness study using a societal perspective to investigate the cost-of-illness of subclinical depressive symptoms among adolescents. METHODS: Using a bottom-up approach, cost questionnaires were assessed to measure costs from 237 Dutch families with an adolescent aged 11-18 with subclinical depressive symptoms (of which 34 met the criteria of a depressive disorder). The study is registered in the Dutch Trial Register (Trial NL5584/NTR6176; www.trialregister.nl/trial/5584). RESULTS: Our calculations show that adolescents with subclinical depressive symptoms cost the Dutch society more than ?42?million annually, expressed in costs related to depressive symptoms. Secondary analyses were performed to test the reliability and stability of the costs. When costs related to psychological problems were considered, the annual costs amounted to ?67?million. The total societal costs related to physical problems amounted to approximately ?126?million. All costs combined (depressive, psychological, behavioural and physical problems and other reasons) amounted to a ?243?million. Total costs were highest for physical-related problems of the adolescent (52% of the total costs), followed by psychological (28%), depressive (17%) and behavioural problems (1%). Using an international prevalence rate, societal costs related to depressive symptoms resulted in ?54?million a year. CONCLUSIONS: Cost-effective prevention programmes seem warranted given the high societal costs and risk of future costs as subclinical depressive symptoms could be a precursor of clinical depression later in life. En ligne : http://dx.doi.org/10.1111/jcpp.13517 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=477

---

1 (1 - 3 / 3)